Fundación Grupo Efecto Positivo Opposition, Tozinameran (Bnt162b2) Covid 19 M Rna Vaccine, (P20210101008 (Ar121859 A1))
No Annotations
Alert me when there are new annotations for this document
7 similar patent oppositions
-
Fundación Grupo Efecto Positivo opposition, Remdesivir, (WO2016069826 (A1))
Countries: Argentina Date: 2020
-
Fundación Grupo Efecto Positivo opposition, Molnupiravir (MK-4482), (AR12285A1)
Countries: Argentina Date: 2022
-
Fundación Grupo Efecto Positivo opposition, Remdesivir (GS-5734), (AR109850)
Countries: Argentina Date: 2020
-
Fundación Grupo Efecto Positivo opposition, Remdesivir (GS-5734), (AR111490)
Countries: Argentina Date: 2020
-
Fundación Grupo Efecto Positivo opposition, Remdesivir (GS-5734), (AR112271 (ARP180101926))
Countries: Argentina Date: 2020
-
Fundación Grupo Efecto Positivo opposition, Nirmatrelvir and Ritonavir [PAXLOVID], (AR123111A1)
Countries: Argentina Date: 2022
-
Fundación Grupo Efecto Positivo opposition, Remdesivir (GS-5734), (AR102468)
Countries: Argentina Date: 2021